Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of develo** hepatocellular carcinoma (HCC). Even after complete HCC …

Representatives from academia, industry, regulatory agencies, and patient groups
convened in March 2019 with the primary goal of develo** agreement on chronic hepatitis …

Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Background & Aims In treated patients with chronic hepatitis B (CHB) who have achieved
complete viral suppression, it is unclear if functional cure as indicated by hepatitis B surface …

Background & Aims Progression of liver fibrosis still occurs in some patients with chronic
hepatitis B virus (HBV) infection despite antiviral therapy. We aimed to identify risk factors for …

ABSTRACT Background & Aims The WHO declared to eliminate hepatitis B virus (HBV) by
2030. However, an increasing number of patients are presenting with low-level viremia …

To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major
public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese …

Background & Aims Chronic hepatitis B (CHB) and liver fibrosis are associated with a high
risk of hepatocellular carcinoma (HCC) development. We assessed whether entecavir (ETV) …

Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC)
in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors …